In conclusion, we provide the first evidence that de-regulated Jak3/STAT3/STAT5 signalling in CTCL cells represses the expression of the gene encoding miR-22, a novel tumor suppressor miRNA. The gene discussed is JAK3; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.